Skip to main content
. 2022 Dec 20;12(5):560–574. doi: 10.1002/psp4.12889

FIGURE 4.

FIGURE 4

Dosing, pulmonary PK, and systemic PK following orally inhaled drug product administration. GI, gastrointestinal; PK, pharmacokinetics. Reprinted from International Journal of Pharmaceutics, 549, Hatipoglu MK, Hickey AJ, Garcia‐Contreras L, Pharmacokinetics and pharmacodynamics of high doses of inhaled dry powder drugs, 306–316, Copyright 2018, with permission from Elsevier. 58